From AureoWiki
Jump to navigation Jump to search

Summary[edit | edit source]

  • pan ID?: SAUPAN004914000
  • symbol?: murT
  • synonym:
  • description?: UDP-N-acetylmuramate--alanine ligase

      descriptions from strain specific annotations:

    • UDP-N-acetylmuramate--alanine ligase
    • Mur ligase family protein
    • UDP-N-acetylmuramyl tripeptide synthetase
    • lipid II isoglutaminyl synthase subunit MurT
    • Mur ligase
    • UDP-N-acetylmuramyl tripeptide synthetase, putative
    • UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-diaminopimelate ligase
    • murein peptide ligase
    • mur ligase middle domain protein
    • putative amino acid ligase
    • UDP-N-acetylmuramyl tripeptide synthase
    • UDP-N-acetylmuramyl tripeptide synthetase-like
  • strand?: -
  • coordinates?: 5103082..5104416
  • synteny block?: BlockID0038200
  • occurrence?: in 100% of 34 strains

murT : lipid II isoglutaminyl synthase ligase subunit [1]

• A crystal structure is available : 6GS2

During cell wall synthesis, the staphylococcal peptidoglycan precursor Lipid II is sequestered at the inner leaflet of the cell membrane for final modifications prior to translocation to the extracellular environment. Two final modifications must occur prior to translocation: addition of a pentaglycine crosslink to the peptide stem lysine and an optional amidation of the peptide stem γ-ᴅ-glutamate to generate isoglutamine. The GatD-MurT complex catalyzes the conversion of peptide stem γ-ᴅ-glutamate to isoglutamine. GatD liberates ammonia from L-glutamine and channels it to the MurT subunit which activates the α-carboxylate of peptide stem γ-ᴅ-glutamate with ATP and exchanges the acid-phosphate (or acid-adenylate) with ammonia to generate isoglutamine. Most γ-glutamyl residues are modified and this modification enhances staphylococcal viability and methicillin resistance.

Orthologs[edit | edit source]

    COL:
    N315:
    NCTC8325:
    Newman:
    USA300_FPR3757:
    04-02981:
    SA2981_1848
    08BA02176:
    C248_1965
    11819-97:
    MS7_1927
    6850:
    RSAU_001779
    71193:
    ST398NM01_1985
    ECT-R 2:
    ECTR2_1763
    ED133:
    SAOV_1991
    ED98:
    SAAV_1957
    HO 5096 0412:
    SAEMRSA15_17990
    JH1:
    SaurJH1_1980
    JH9:
    SaurJH9_1946
    JKD6008:
    SAA6008_01912 (murE2)
    JKD6159:
    SAA6159_01823 (murE2)
    JSNZ:
    JSNZ_001922 (murT)
    LGA251:
    SARLGA251_17740
    M013:
    M013TW_1928
    MRSA252:
    SAR1983
    MSHR1132:
    SAMSHR1132_17360
    MSSA476:
    SAS1814
    Mu3:
    SAHV_1877
    Mu50:
    SAV1892
    MW2:
    MW1833
    RF122:
    SAB1824c
    ST398:
    SAPIG1985
    T0131:
    SAT0131_02017
    TCH60:
    HMPREF0772_11251 (murE)
    TW20:
    SATW20_18860
    USA300_TCH1516:
    USA300HOU_1890 (murE2)
    VC40:
    SAVC_08720

Genome Viewer[edit | edit source]

COL
N315
NCTC8325
Newman
USA300_FPR3757

Alignments[edit | edit source]

  • alignment of orthologues:
    CLUSTAL format alignment by MAFFT L-INS-i (v7.307)


    COL             MRQWTAIHLAKLARKASRAVGKRGTDLPGQIARKVDTDILRKLAEQVDDIVFISGTNGKT
    N315            MRQWTAIHLAKLARKASRAVGKRGTDLPGQIARKVDTDVLRKLAEQVDDIVFISGTNGKT
    NCTC8325        MRQWTAIHLAKLARKASRAVGKRGTDLPGQIARKVDTDILRKLAEQVDDIVFISGTNGKT
    Newman          MRQWTAIHLAKLARKASRAVGKRGTDLPGQIARKVDTDILRKLAEQVDDIVFISGTNGKT
    USA300_FPR3757  MRQWTAIHLAKLARKASRAVGKRGTDLPGQIARKVDTDILRKLAEQVDDIVFISGTNGKT
                    **************************************:*********************

    COL             TTSNLIGHTLKANNIQIIHNNEGANMAAGITSAFIMQSTPKTKIAVIEIDEGSIPRVLKE
    N315            TTSNLIGHTLKANNIQIIHNNEGANMAAGITSAFIMQSTPKTKIAVIEIDEGSIPRVLKE
    NCTC8325        TTSNLIGHTLKANNIQIIHNNEGANMAAGITSAFIMQSTPKTKIAVIEIDEGSIPRVLKE
    Newman          TTSNLIGHTLKANNIQIIHNNEGANMAAGITSAFIMQSTPKTKIAVIEIDEGSIPRVLKE
    USA300_FPR3757  TTSNLIGHTLKANNIQIIHNNEGANMAAGITSAFIMQSTPKTKIAVIEIDEGSIPRVLKE
                    ************************************************************

    COL             VTPSMMVFTNFFRDQMDRFGEIDIMVNNIAETISNKGIKLLLNADDPFVSRLKIASDTIV
    N315            VTPSMMVFTNFFRDQMDRFGEIDIMVNNIAETISNKGIKLLLNADDPFVSRLKIASDTIV
    NCTC8325        VTPSMMVFTNFFRDQMDRFGEIDIMVNNIAETISNKGIKLLLNADDPFVSRLKIASDTIV
    Newman          VTPSMMVFTNFFRDQMDRFGEIDIMVNNIAETISNKGIKLLLNADDPFVSRLKIASDTIV
    USA300_FPR3757  VTPSMMVFTNFFRDQMDRFGEIDIMVNNIAETISNKGIKLLLNADDPFVSRLKIASDTIV
                    ************************************************************

    COL             YYGMKAHAHEFEQSTMNESRYCPNCGRLLQYDYIHYNQIGHYHCQCGFKREQAKYEISSF
    N315            YYGMKAHAHEFEQSTMNESRYCPNCGRLLQYDYIHYNQIGHYHCQCGFKREQAKYEISSF
    NCTC8325        YYGMKAHAHEFEQSTMNESRYCPNCGRLLQYDYIHYNQIGHYHCQCGFKREQAKYEISSF
    Newman          YYGMKAHAHEFEQSTMNESRYCPNCGRLLQYDYIHYNQIGHYHCQCGFKREQAKYEISSF
    USA300_FPR3757  YYGMKAHAHEFEQSTMNESRYCPNCGRLLQYDYIHYNQIGHYHCQCGFKREQAKYEISSF
                    ************************************************************

    COL             DVAPFLYLNINDEKYDMKIAGDFNAYNALAAYTVLRELGLNEQTIKNGFETYTSDNGRMQ
    N315            DVAPFLYLNINDEKYDMKIAGDFNAYNALAAYTVLRELGLNEQTIKNGFETYTSDNGRMQ
    NCTC8325        DVAPFLYLNINDEKYDMKIAGDFNAYNALAAYTVLRELGLNEQTIKNGFETYTSDNGRMQ
    Newman          DVAPFLYLNINDEKYDMKIAGDFNAYNALAAYTVLRELGLNEQTIKNGFETYTSDNGRMQ
    USA300_FPR3757  DVAPFLYLNINDEKYDMKIAGDFNAYNALAAYTVLRELGLNEQTIKNGFETYTSDNGRMQ
                    ************************************************************

    COL             YFKKERKEAMINLAKNPAGMNASLSVGEQLEGEKVYVISLNDNAADGRDTSWIYDADFEK
    N315            YFKKERKEAMINLAKNPAGMNASLSVGEQLEGEKVYVISLNDNAADGRDTSWIYDADFEK
    NCTC8325        YFKKERKEAMINLAKNPAGMNASLSVGEQLEGEKVYVISLNDNAADGRDTSWIYDADFEK
    Newman          YFKKERKEAMINLAKNPAGMNASLSVGEQLEGEKVYVISLNDNAADGRDTSWIYDADFEK
    USA300_FPR3757  YFKKERKEAMINLAKNPAGMNASLSVGEQLEGEKVYVISLNDNAADGRDTSWIYDADFEK
                    ************************************************************

    COL             LSKQQIEAIIVTGTRAEELQLRLKLAEVEVPIIVERDIYKATAKTMDYKGFTVAIPNYTS
    N315            LSKQQIEAIIVTGTRAEELQLRLKLAEVEVPIIVERDIYKATAKTMDYKGFTVAIPNYTS
    NCTC8325        LSKQQIEAIIVTGTRAEELQLRLKLAEVEVPIIVERDIYKATAKTMDYKGFTVAIPNYTS
    Newman          LSKQQIEAIIVTGTRAEELQLRLKLAEVEVPIIVERDIYKATAKTMDYKGFTVAIPNYTS
    USA300_FPR3757  LSKQQIEAIIVTGTRAEELQLRLKLAEVEVPIIVERDIYKATAKTMDYKGFTVAIPNYTS
                    ************************************************************

    COL             LAPMLEQLNRSFEGGQS
    N315            LAPMLEQLNRSFEGGQS
    NCTC8325        LAPMLEQLNRSFEGGQS
    Newman          LAPMLEQLNRSFEGGQS
    USA300_FPR3757  LAPMLEQLNRSFEGGQS
                    *****************

  1. Daniela Münch, Terry Roemer, Sang Ho Lee, Marianne Engeser, Hans Georg Sahl, Tanja Schneider
    Identification and in vitro analysis of the GatD/MurT enzyme-complex catalyzing lipid II amidation in Staphylococcus aureus.
    PLoS Pathog: 2012, 8(1);e1002509
    [PubMed:22291598] [WorldCat.org] [DOI] (I p)
    Erik R Nöldeke, Lena M Muckenfuss, Volker Niemann, Anna Müller, Elena Störk, Georg Zocher, Tanja Schneider, Thilo Stehle
    Structural basis of cell wall peptidoglycan amidation by the GatD/MurT complex of Staphylococcus aureus.
    Sci Rep: 2018, 8(1);12953
    [PubMed:30154570] [WorldCat.org] [DOI] (I e)
    Maria D Barbuti, Ine S Myrbråten, Danae Morales Angeles, Morten Kjos
    The cell cycle of Staphylococcus aureus: An updated review.
    Microbiologyopen: 2023, 12(1);e1338
    [PubMed:36825883] [WorldCat.org] [DOI] (I p)